Radiometer logo

The Benefits of Continuous CO2 and O2 Monitoring in the NICU

November 14, 2017

Webinar presented by Olivier Danhaive, MD; Professor of Pediatrics, University of California San Francisco; and Director of the Infant Care Center, Zuckerberg San Francisco General Hospital.

Playback

Slides

About this webinar

Continuous measurement of oxygenation and ventilation status detects sudden changes in the respiratory status in the fragile neonate. Premature and critically ill babies in the NICU are fragile and at risk of sudden changes in oxygenation (pO2) and carbon dioxide (pCO2) levels which can cause severe complications.

Transcutaneous monitoring in neonates provides a real-time overview of the patient’s often fluctuating oxygenation (tcpO2) and ventilation (tcpCO2) status. During this webinar, Dr. Olivier Danhaive will describe the main indications for monitoring in the NICU, including: 

  • High Frequency Oscillatory Ventilation
  • Clinical benefits of transcutaneous monitoring (TCM) as part of Neonatal Blood Mangement (including other technologies like etCO2, spO2 and Blood Gas), in terms of patient safety and accuracy
  • and, most importantly, the interpretation of transcutaneous values in different clinical cases.

About the speaker

Olivier Danhaive, MD Professor of Pediatrics University of California San Francisco, Director of the Infant Care Center, Zuckerberg San Francisco General Hospital.

Olivier Danhaive, M.D. is an American Academy of Pediatrics board-certified neonatologist and a professor of Pediatrics at University of California San Francisco. He completed his Pediatrics residency at the Catholic University of Louvain in Brussels, Belgium and Neonatal-Perinatal Medicine fellowship at Harvard University.

One of his main clinical focuses is the respiratory management of the neonate with acute and chronic lung disease. His research interests reside in the genetics of lung development and diseases such as congenital surfactant deficiencies, bronchopulmonary dysplasia and pulmonary hypertension.

 

Who should attend?

  • Neonatalogists
  • Pediatricians
  • Respiratory therapists
  • Nursing Leadership Teams

Continuing education

  • This program has been approved for 1 CRCE Contact Hour by the American Association for Respiratory Care (AARC)
  • General certificate of attendance

This webinar will:

  • Discuss the characteristics and indications of using Transcutaneous Monitoring (TC)  in the NICU
  • Compare TC monitoring application, indication and effectiveness to other technologies like EtCO2, SpO2 and Blood Gas 
  • Using clinical cases, examine the interpretation of TC results and corresponding actions physicians can take

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

Sorry

It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.

Effective Date January 20th, 2023 (last updated January 20th, 2023)

ABOUT THIS POLICY

Radiometer values your privacy and the protection of your personal data. This policy (“Policy”) explains how Radiometer its affiliates, subsidiaries or related companies, a full list of which can be located here (together, “Radiometer”, “our”, “us”, or “we”), collects, uses, shares, transfers and processes data collected from or about you.


Personal Data” is any information that can be used to directly or indirectly identify an individual or that can be reasonably expected to link to an individual. This can include items such as name, address, telephone number, credit card details, email address, ID number, Internet Protocol (“IP”) address of an electronic device used by an individual, or other identifying code (even absent of other identifying information). Statistical and non-identifiable metric data are not considered Personal Data.

The Radiometer subsidiary, affiliate or related company with which you interact is, where applicable, the data controller (or equivalent under applicable law) responsible for the processing of your Personal Data. You can find a list of the relevant legal entities that act as data controllers in Appendix 1 to this Policy.

SCOPE

This Policy describes the types of Personal Data that we may collect, process or disclose about you and how you may govern this processing by exercising applicable legal rights. This Policy applies to both online and offline information collection, including your use of websites or subdomains operated by us, any mobile applications, when we provide products and/or services to you or notify you about prospective items of interest and in other situations where you interact with us in-person, by telephone or by mail where this Policy is posted or referenced.


There may be occasion where you have been provided with a circumstance-specific privacy notice that is separate from this policy, such as privacy notices for specific activities such as Recruitment. To the extent you were provided with a different notice, those notices apply and govern our interactions with you. If you provide Personal Data about parties other than yourself, you are responsible for ensuring their knowledge of how we will process their personal data, and, where applicable, obtaining any necessary consents required in advance.

We are committed to processing Personal Data in accordance with applicable laws. Please note that if you do not wish to provide your Personal Data to us, some products and/or services may become unavailable to you. Your use of any or all these platforms indicates you have been notified of our collection, use, transfer, and disclosure of your information as described in this Policy to the extent permitted by applicable law.

Read more